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Chronic infection during placental malaria is
associated with up-regulation of cycloxygenase-2
Demba Sarr1, Delphine Aldebert1, Laurence Marrama1, Emilie Frealle1, Alioune Gaye2, Hamoud O Brahim1,
Makhtar Niang1, Jean Marie Dangou1, Odile Mercereau-Puijalon3, Jean Yves Lehesran4, Ronan Jambou1,5*
Abstract
Background: Placental malaria (PM) is associated with poor foetal development, but the pathophysiological
processes involved are poorly understood. Cyclooxygenase (COX) and lipoxygenase (LOX) which convert fatty acids
to prostaglandins and leukotrienes, play important roles in pregnancy and foetal development. COX-2, currently
targeted by specific drugs, plays a dual role as it associates with both pre-eclampsia pathology and recovery
during infection. The role of COX during PM was questioned by quantifying at delivery COX-1, COX-2, 15-LOX, and
IL-10 expression in two groups of malaria infected and uninfected placenta.
Methods: Placental biopsies were collected at delivery for mRNA isolation and quantification, using real time PCR.
Results: COX-2 and IL-10 mRNAs increased mainly during chronic infections (nine- and five-times, respectively),
whereas COX-1 transcripts remained constant. COX-2 over-expression was associated with a higher birth weight of
the baby, but with a lower rate of haemoglobin of the mother. It was associated with a macrophage infiltration of
the placenta and with a low haemozoin infiltration. In the opposite way, placental infection was associated with
lower expression of 15-LOX mRNA. A high degree of haemozoin deposition correlates with low birth weight and
decreased expression of COX-2.
Conclusion: These data provide evidence that COX-2 and IL-10 are highly induced during chronic infection of the
placenta, but were not associated with preterm delivery or low birth weight. The data support the involvement of
COX-2 in the recovery phase of the placental infection.
Background
In Africa, most of the malaria mortality and morbidity is
borne by children and pregnant women with an esti-
mate 200,000 infant deaths each year as a result of
malaria infection in pregnancy [1]. During placental
malaria (PM) parasites accumulate in the placenta with
an increased risk of low birth weight (LBW) [2]. This
accumulation can be related to low blood flow through
the placenta and to specific adhesion of infected red
blood cells (IRBCs) on syncytiotrophoblast. This adhe-
sion is mediated by chondroitin sulphate A and specific
var antigens. Monocytes also accumulate in the intervil-
lous space of the placenta [3] mostly attracted by release
of MIF [4,5]. Pro-inflammatory cytokine release also
associates with this accumulation of parasites, pigment,
and monocytes in the tissue [6,7].
Decreased blood flow in the placenta is the major fac-
tor triggering LBW, which had previously been linked to
a modulation of placental cytokine expression [7]. In
this context, prostaglandins (PGs) are important modu-
lators of vascular perfusion and fever [8]. Conversion of
arachidonic acid to PGs is catalyzed by two isoforms of
cyclooxygenase (COX-1 and COX-2) [9]. COX-2-gener-
ated PGs are important in inflammation and host
defence and is up-regulated prior to the onset of labour
[10,11]. Whereas COX-1-generated PGs is implicated in
homeostasis and survival of the foetus, and mainly
secreted in decidual lining of the uterus [12,13] without
modulation during gestation or labour. The role of
COX-1 and -2 during placental pathology was suspected
some time ago when bacterial lipopolysaccharide
mediated foetal death was related to an over-production
of COX-2 [14]. In the same line COX-2 over expression
was reported during pre-eclampsia [15], but not after
this episode [16] and was associated with apoptosis in
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smooth chorion trophoblast cells of human foetal mem-
brane tissues [17]. This enhancement seems to be trig-
gered by leukocyte microparticles [15,18]. However,
Khan et al published conflicting results describing a
reduction of COX-2 and of the amount of NHE-1 in
pre-eclamptic placentas with an unaltered level of COX-
1 [19].
During placental malaria, modulation of these PGs
pathway could play a role in preterm delivery and low
birth weight as observed during pre-eclampsia. A foetal
COX-2 gene polymorphism was associated with placen-
tal malperfusion during placental malaria [20]. In the
general, circulation PGE2 and blood mononuclear cell
COX-2 expression were also reported to be inversely
related with disease severity in children with malaria
[21,22].
Two other arachidonic acid pathways, the epoxide and
the lipoxygenase (LOX) pathway [23], are involved in
pathology during pregnancy [24]. LOX leads to synthesis
of leukotrienes and lipoxins with immune and anti-
inflammatory activity. Three enzymes control this path-
way: 5-LOX produced by neutrophils, 12-LOX produced
by platelets, and 15-LOX located in macrophages and
endothelia. 15-LOX is highly inducible and produces
hydroxyeicosatetraenoic (HETE) compounds [25]. Inter-
estingly, 15-HETE is a powerful inhibitor of pro-inflam-
matory eicosanoids, whereas 5-HETE and 12-HETE are
chemotactic factors for neutrophils and they also stimu-
late vasodilation through PG synthesis [26].
Eicosanoids are thus powerful regulators of placenta
perfusion and overall of the pregnancy outcome. New
analgesic and anti-inflammatory drugs, inhibitors of
COX activity, are often used in malaria endemic areas
to reduce fever, pain, and inflammation [27]. They can
interfere with PGs regulations and modulate the out-
come of the pregnancy even if antenatal administration
of celecoxib (a COX-2 inhibitor) seems to improve pla-
cental perfusion in the pregnant rabbit [28]. All these
data pave the way of new studies to understand the
pathophysiology of placental malaria, and this study was
designed to address the role of these enzymes during
PM in low malaria transmission area. The purpose of
this study was to evaluate the levels of COX-1, COX-2,
and 15-LOX mRNA genes in human placenta infected
by P. falciparum compared to uninfected placenta.
Although delivery is only an instant in the whole preg-
nancy, it is however a good snapshot of the placenta
statement. Studies conducted at delivery also give infor-
mation on the late stage of the mother-baby interaction.
Methods
Placenta collection
Collection of placentas was done at delivery, at the
maternity ward the Centre de Santé Roi Baudoin,
Guediawaye, Dakar Sénégal. Details regarding enrolment
and standard laboratory procedures have been reported
elsewhere [29]. It involved women, more than 16 years,
with an uncomplicated delivery of live newborns. For all
women giving informed consent, an immuno-chromato-
graphy test (ICT, PfHRP2 MaKromed) was carried out
on placental blood. A standard questionnaire was used
to record information including: mother’s age, gravidity,
gestational age (determined by the date of the last men-
strual period and morphometric measurement of the
uterus during antenatal clinic visits) and history of
malaria attacks. Babies and placentas were weighed
immediately after birth. Gender and Apgar scores were
recorded. LBW was defined as < 2,500 g, and prematur-
ity as gestational age < 37 weeks. Women with haemo-
globin (Hb) less than 11 g/dl were considered anaemic.
The HIV infection status of the participants was not
established at the time of the study however, HIV sero-
prevalence in Senegalese population was low (0.8% of
parturients in Dakar) [30]. All ICT-positive women
received chloroquine after delivery. Anaemic women
received iron and folic acid supplements.
After collection, whole placentas were refrigerated
until assessment (less than two hours after delivery). For
each placenta, four biopsies were sampled [31], rinsed in
phosphate buffer saline (PBS), rapidly frozen in liquid
nitrogen and stored at -80°C until RNA extraction. An
additional four biopsies were sampled for histology and
immunohistochemistry studies.
Histology and immunohistochemistry
Immediately after collection, samples for histology and
immunohistochemistry were fixed in 4% buffered paraf-
ormaldehyde and processed as previously described [29].
5 μm cryosections were stained either with haematoxy-
lin-eosin (H&E) or with May-Grünewald-Giemsa
(MGG). Quantification of parasites was done in placenta
for 100 fields (magnification 1000×) of MGG stained
sections and in blood by examination of Giemsa-stained
thick smears. Haemozoin (HZ) was identified on sec-
tions as brown granular material with high refringence
on polarization microscope, which differentiates then
from formalin crystals. Contain in HZ was qualitatively
assessed on sections as: no HZ, low HZ (1-2 crystals/
field at ×1000) or high HZ (> 2/field).
Acute infections (AI) were defined by the presence of
parasites on sections without malaria pigment, chronic
infections (CI) by presence of parasites and pigment,
and past infections (PI) by the presence of pigment
alone. PfHRP2+ placentas with no evidence of parasites
or pigment were classified as “no-parasite” (NP). For the
control group all PfHRP2 rapid diagnosis test, parasites
and pigment detection were negative in placenta and in
the venous blood.
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For immunochemistry, after blocking endogenous perox-
idases and non-specific binding, tissue sections were incu-
bated for 1 h at room temperature with primary antibodies
or control isotypes and revealed using LSAB detection kit
(DakoCytomation). Antibodies used were CD68 (PG-M1),
and HLA-DR (TAL.1B5) from DakoCytomation mouse
antibodies against. The number of cells in the intervillous
space was counted over 100 fields (magnitude ×400).
mRNA quantification
Frozen biopsies were ground into powder in liquid nitro-
gen before homogenization in 4 M guanidium buffer.
RNAs were extracted using standard phenol-chloroform
procedure, precipitated with isopropanol and washed
before quantification. Integrity of total RNA was assessed
on an ethidium bromide (EtBr) stained denaturing agar-
ose gel. For reverse transcription 2 μg of RNA was dena-
tured at 65°C for 10 min, cooled on ice-water, and
reverse-transcribed for 60 min at 43°C with 40 U/μl
RNase inhibitor and oligo-dT. Amplification was per-
formed in an ABI Prism 7000 Sequence Detection System
using Taqman Universal PCR Master Mix (PE Biosys-
tems), containing 300 nM of primers and 200 nM of
fluorogenic probes. Each measurement was carried out in
duplicate and amplification of Peptidyl Propyl Isomerase
A (PPIA, also called Cyclophylin A) was conducted on
the same plate. Others housekeeping genes such as beta-
2-microglobulin and beta-actin were run together with
PPIA, but were not selected for standardization as less
constant between infected and uninfected placentas.
Probes and primers (Table 1) were designed using Primer
Express software (Applied Biosystems). Cycling condi-
tions started at 50°C for 2 minutes followed by 95°C for
10 minutes, then 40 cycles of 95°C for 15 seconds and
60°C for 1 minute. The specificity of PCR amplifications
was confirmed for each set of primers by sequencing of
the PCR product and primers specificity was confirmed
by single peaks demonstrated by dissociation curves after
amplification of cDNA. The amplification efficiency was
assessed for all the genes by amplifying serial dilutions of
cDNA, and calculation of the slope (delta Ct)/(log cDNA
dilution) which must be less than 0.1. Quantification of
gene expression was done according to Livak et al [32]
using for each gene the mean Ct-values of the duplicate.
For each sample the results were adjusted according to
the level of PPIA in the same sample. The PfHRP2-nega-
tive control group was used to normalize the results. For
each gene, the relative quantity (RQ) of mRNA was
expressed, in arbitrary units, as a fold increase in compar-
ison with the control group.
Statistical analysis
Differences between groups were compared using
Mann-Whitney U test (MW) for two groups or with
Kruskal-Wallis test (KW) and Median test for more
than two. Correlations were calculated using a Spear-
man R test (SP). Alpha risk was set at 0.05.
Results
Chronic infection is associated with lower birth weight
During this study, 692 pregnant women were exam-
ined among whom 71 had a Plasmodium falciparum
histidine rich protein positive-RDT (PfHRP2+)
(10.3%). For these PfHRP2+ women, 25% of the
babies had LBW and 67% of the women were anae-
mic [29]. Compared to the control women, chronic-
active infections were associated with lower birth
weight (p < 0.008 and p < 0.0002 respectively) as well
as CI and PI correlated with lower haemoglobin levels
(p < 0.05 for both). No significant change was found
for birth weight and haemoglobin, according to parity
may be due to the low sample size of the study. For
the purpose of this study, 54 placental samples were
randomly selected from the different histological
groups after classification (table 2). Among the
selected PfHRP2+ women, 13 were primiparous, 13
secundiparous, and 14 multiparous.
Past and chronic infections are associated with a higher
level of COX-2 and IL-10 mRNA
COX-2 mRNA increased during PM especially during
late stage of the infection: 9.0, 5.4, 3.8 and 3-time higher
in placentas with CI, AI, PI and NP, respectively, than
in the control group (p < 0.01 MW for CI and AI). The
expression of COX-1 remained low in all the placentas
without significant differences between PfHRP2- (Ctrl)
and PfHRP2+ (CI, AI, PI & NP) groups, but trends to
increase during past infection (Figure 1A).
Because IL-10 has been shown to exert direct regula-
tory effects on prostaglandin production, we also mea-
sured IL-10 mRNA in our placental samples. The levels
of IL-10 transcripts were higher in PfHRP2+-placentas
than in controls (MW p = 0.004, Figure 1A) and corre-
lated with COX-2 expression (n = 54, SP p = 0.006 R =
0.36; and p = 0.008 R = 0.36). However none of these
markers correlated with the parasitaemia. In the oppo-
site way 15-LOX was lower in PfHRP2+-placentas than
in controls (MW p = 0.0002) (Figure 1A), but correlates
with parasitaemia in the placenta (SP R = 0.416, p =
0.0076) and with COX-2 mRNA expression (SP p =
0.018, R = 0.37).
The levels of COX-2 mRNA but not of COX-1, 15-
LOX, and IL-10, trend to decrease when parity
increased (Figure 1B), but there was no significant dif-
ference for any of these genes according to duration
of the pregnancy or with the presence of fever at
delivery.
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Elevated level of COX-2 is associated with anaemia in the
mother but not with low birth weight
Birth weight was significantly lower in primiparous than
in secundiparous or multiparous (MW p < 0.05 for
both). It was also lower during AI and CI than in con-
trol group. However, women who delivered babies with
normal birth weight had higher level of COX-2 tran-
scripts compared to others (MW p < 0.02; Figure 2B).
In the opposite way COX-1 and 15-LOX transcripts
trend to increase in association with LBW (respectively
2 and 1 fold increase than for the normal birth weight
group, NS Figure 2B).
Haemoglobin was inversely related to the level of
COX-1, COX-2 and IL-10 but increased with 15-LOX
(SP R = -0.58, -0.57, -0.51, 0.48 respectively, p < 0.001
for each) (Figure 2A). Haemoglobin tends to decrease
with the amount of HZ in the placenta (Figure 3A, mid-
dle panel; NS). Anaemia was thus associated with an
increase of COX-2 and with PI (MW p < 0.001, with
control group).
COX-2 expression increase with macrophage recruitment
and with decrease of pigment deposit
High level of pigment in the placenta was associated
with significantly lower birth weight (KW p = 0.013, n =
44, Figure 3A, left panel), and with lower haemoglobin
level in the mother (KW p = 0.018, Figure 3A, middle
panel). However lower pigment density associated with
a higher level of COX-2 and IL-10 transcripts (Figure
3d), without significant change for COX-1 (MW, p <
0.001 for both).
As detected by immunohistochemistry (Figure 3c),
macrophages (CD68+) and activated HLADR+ present-
ing cells increased in PfHRP2+-placenta (p < 0.001 for
both, DNS), mainly during late infection (CI or PI ver-
sus Ctrl: MW p < 0.001). Primiparous and
Table 1 Nucleotides sequences of the primers and probes used for real time PCR. PPIA: Peptidyl Propyl Isomerase A.
Human Gene Accession number Sequences
(a: Probe, b: Primer F, c: primer R)
Amplicon size (bp)
COX-1 NM_000962 a) Fam-CTG GCC TCA GCA CTC TGG AAT GAC AA-Tamra
b) ATG ATG GGC CTG CTG TGG A
c) CCA ACA CTC ACC ATG CCA AAC
150
COX-2 NM_000963 a) Fam-TGC CCA GCA CTT CAC GCA TCA GTT-Tamra
b) GCT CAA ACA TGA TGT TTG CAT TC
c) GCT GGC CCT CGC TTA TGA
79
15-LOX NM_001140 a) Fam-TCC ACC AGG CTT CTC TCC AGA TGT CC-Tamra
b) GGA GAC AGT GAT GGC GAC ACT
c) TCT GCC CAG CTG CCA AGT
74
PPIA NM_021130 a)Fam-AGC TCA AAG GAG ACG CGG CCC A-Tamra
b) GTC AAC CCC ACC GTG TTC TT
c) CTG CTG TCT TTG GGA CCT TGT
73
IL-10 NM_000572 a)Fam-CAG GCA ACC TGC CTA ACA TGC TTC-Tamra
b) TGA GAA CAG CTG CAC CCA CTT
c) ATC TCC GAG ATG CCT TCA GC
70
Table 2 Clinical and laboratory data of enrolled women according to the class of infection.
Variables Ctrl
(PfHRP2-)
Total
(PfHRP2+)
NP Past I Acute I Chronic I
No. of women 14 40 10 10 10 10
Primigravidae n (%) 4 (28) 13 (32.5) 3 (30) 3 (30) 3 (30) 4 (40)
Secundigravidae n (%) 5 (36) 13 (32.5) 3 (30) 3 (30) 3 (30) 3 (30)
Multigravidae n (%) 5 (36) 14 (35) 4 (40) 4 (40) 4 (40) 3 (30)
Age (years) 24.6 ± 1.6 25.6 ± 1.13 25.2 ± 2.3 26.6 ± 0.6 26.0 ± 1.96 24.8 ± 2.3
Pregnancy duration, weeks 40.8 ± 1.2 40.5 ± 2.6 41.1 ± 1.1 40.9 ± 0.9 41.1 ± 1.1 41.3 ± 1.3
Birth weight (g) 3,153 ± 93 2,723 ± 93* 2,995 ± 137 2,623 ± 131* 2,862 ± 167 2,411 ± 251*
Haemoglobin (g/dl) 11.9 ± 0.3 9.4 ± 2.5* 10.2 ± 1.2 8.5 ± 0.4* 8.4 ± 1.1* 10.2 ± 0.9
Parasitaemia, Venous 0 83% 0 0 205.5% 35.3%
Parasitaemia, Placental 0 294% 0 0 644.5% %
(*) means significant when compared with the control group (p < 0.05)
NP (no parasites): PfHRP2 positive placenta without parasites or pigment detected by microscopy; PI (past infection): only pigment detected by microscopy; AI
(acute infection): only parasites detected; CI (chronic infection): parasites and pigment detected; control (Ctrl): uninfected women with PfHRP2 negative placenta.
Data are mean ± SE. Parasitaemia are expressed as parasites per 100 leukocytes. (*) significant difference with control group (p < 0.01 Mann Whitney U test).
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Figure 1 Expression of COX-1, COX-2, 15-LOX and IL-10 mRNA in placenta. Expression levels was calibrated for each gene using PPIA as
housekeeping gene (delta Ct = Ctgene - CtPPIA) and normalized using the pool of uninfected control placentas (delta delta Ct = delta Ct -
mean delta Ct (ctrl)). Results are plotted according to: (A) infection classes: CI = Chronic Infections, AI = Acute Infections, PI = Past Infections, NP
= No parasites/pigment detectable, Ctrl = uninfected placentas (PfHRP2-) (B) Parity: P = primiparous, M = multiparous, and S = secondiparous
women. RQ = Relative Quantity = 2-(deltadelta Ct). P value are indicated for significant test only (p < 0.05).
Figure 2 Expression of COX-1, COX-2, 15-LOX and IL-10 mRNAs in placenta. Expression levels of each gene (calibrated as in Fig.1) plotted
according to (A) haemoglobin level of the mother (g/100 ml) (B) Birth weight of the newborn. Hb = hemoglobin; BW = birth weight; RQ =
Relative quantity. P value are indicated for significant test only.
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secondiparous women exhibited higher levels of CD68+
cells when compared to multiparous (p < 0.05) while CI
had significantly higher levels of CD68+ cells compared
to PfHRP2- or control (p = 0.002). The density of
macrophages (CD68) increased in the placenta when the
amount of pigment was low (median test p < 0.0001).
The count of macrophage was significantly correlated
with COX-2 (SP p = 0.014, R = 0.331), IL-10 (SP p =
0.014, R = 0.332) and 15-LOX mRNA (SP p = 0.0003, R
= 0.539). In the placental tissue sections COX-1 protein
was detected by immunolabelling in trophoblasts,
mononuclear interstitial cells and, most often, in foetal
endothelial cells. COX-2 and 15-LOX were mainly
detected in macrophages, endothelial cells and tropho-
blasts. During past and chronic infection, COX-2 was
highly expressed in trophoblasts (Sarr, personal
communication).
Discussion
This study is part of a project conducted on the patho-
physiology of PM in West African urban areas. Despite
the low transmission rate of malaria, a high prevalence
Figure 3 Impact of the charge of pigment in the placenta. For PfHRP2+ placenta, the pigment deposit was plotted as: “no pigment” (No);
“low load of pigment” (low) for less than 3 pigments for 10 field (×400); “high load of pigment” (high) for more than 3 pigments per field;
“control group” (Ctrl) for PfHRP2- placenta. A) Relation between charge in pigment and birth weight of the newborn (g), B) Relation between
charge in pigment and haemoglobin level of the mother (g/100 ml), C) Relation between charge in pigment and count of CD68+ and HLA-DR
cells in the placenta (number of cells/100 fields at magnification ×400). D) Relation between charge in pigment and expression level of the four
genes (RQ = Relative Quantity = 2-(deltadelta Ct)). NS = not significant, (*) means significant when compared with the control group.
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of PM was observed in this area [29], but its pathogen-
esis is still poorly understood.
As previously described [11] COX-1 expression
remained low in all the samples of our study, in com-
parison with COX-2. COX-2 expression clearly
increased after long-term malaria active infection (CI) of
the placenta. Consistent with previous reports [3],
chronic infection was associated with a macrophage
infiltration of the placenta, which correlated with COX-
2 over-expression. In placenta COX-2 was mainly
detected in macrophages, vascular lymphocytes and
fibroblasts [16], which can explain this correlation.
These data indicate that low amount of pigment was
associated with the highest levels of COX-2 and IL-10
transcripts, whereas, high amount of HZ was associated
with a lower COX-2 expression. In the same line,
women with high amount of HZ had babies with lower
birth weights and lower level of haemoglobin. This is in
line with data showing inhibition of intervillous blood
mononuclear cells (IVBMCs) charged in HZ and in par-
ticular suppression of PGE2, TNF, and IL-10 secretion
[33,34]. This phagocytosis of haemozoin was reported i)
to enhance matrix metalloproteinase-9 activity and TNF
production in human monocytes [35,36], and ii) to
reduce immune response by an activation of a Toll-like
receptor 9 mediates mechanism [37]. Overall a low
charge in HZ could be a signal to attract macrophages
and stimulates cells whereas a high charge could inhibit
them.
All these data are consistent with an inflammatory
process [3,38]. However, COX-2 (unrelated to the term
of the pregnancy) was positively correlated with the
birth weight, which supports a protective role of this
process for the foetus development. Macrophages can
also participate in this protective role, as well as prosta-
cyclins secreted by chorion endothelium, which are
known to induce relaxing of foetal vasculature [26].
High level of COX-2 was also previously associated with
recovery from anaemia [39]. Along the same lines, IL-10
mRNA was significantly higher in infected placentas
compared to uninfected ones, as previously described
[40,41]. High level of IL-10 could be deleterious, as IL-
10 is known to inhibit COX-2 expression in preterm
human placenta [42] and secretion of inflammatory
cytokines by monocytes [43]. It was also associated with
high parasitaemia, severe anaemia and a low level of
COX-2 in PBMC [8,22].
However this could not be relevant during PM as i)
COX-2 seems mainly expressed by placenta and not by
PBMC and as ii) the effect of IL10 on COX-2 and PGE2
seems to be different in preterm and in term placentas
[42]. In the same line, IFN-gamma and oestrogen recep-
tor-beta modulates COX-2 expression in human
placental villous endothelial cells [44,45] and need to be
measured.
Interestingly, 15-LOX expression correlated with the
presence of parasites in the intervillous space, which is
consistent with study stating that 15-HETE and 15-
HPETE stimulated red blood cell adhesion to endothe-
lium [46]. However 15-LOX mRNA expression
remained lower in infected samples compared to unin-
fected or control samples, which can exclude its role in
the sequestration of parasites in the placenta.
Conclusion
In summary, this study showed that COX-2 and IL-10
are highly expressed in active PM. COX-2 correlates
with macrophage infiltration and is related to a better
outcome of the pregnancy with higher birth weight. All
these data support the increase of COX-2 as a witness
of placental defence against infection and draw attention
on uncontrolled use of anti-COX2 during placental
malaria.
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